Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Overview

Business, legal identity, ownership structure and classifications.

What the company does

About

Alpha's canonical identity and public leadership record for Vaxcyte, Inc..

Sector and industry values retain their source labels. A classification provider, taxonomy version and assignment date are not established unless the cited record states them.

Stable business record

Identity and status

Ownership and listing state

Public listing published

Ownership not asserted

The canonical public record includes at least one active security listing.

Inspect status source
Legal name
Vaxcyte, Inc.
Inspect source
Country
US
Inspect source
Sector
Healthcare
Inspect source

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 24, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Relationships and related records

Connections

Explore the roles, education and affiliations published in this record.

Andrew L. Guggenhime

Open Andrew L. Guggenhime profile →

Andrew L. Guggenhime: President & Chief Financial Officer

Start not stated → End not stated

Date not established · source reported

Observed: 2026-09-24

Andrew L. GuggenhimeAndrew L. GuggenhimeAnnie DrapeauAnnie DrapeauCarlos Paya, M.D.,…Carlos Paya, M.D., Ph.D.Elvia CowanElvia CowanGrant E. PickeringGrant E. PickeringGrant E. PickeringGrant E. PickeringHalley GilbertHalley GilbertHarp DhaliwalHarp DhaliwalJacks LeeJacks LeeJames WassilJames WassilJanet GraesserJanet GraesserJim WassilJim WassilVaxcyte, Inc.

Dashed lines mark past roles. Select a connection to see its dates and sources.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · canonical_identityAlpha canonical company public projectionSupports Company identity, Published leadership, Entity status boundary. Reviewed Sep 24, 2026.Open source

Board & Leadership

Board leadership, management, committees and their disclosed responsibilities.

Committee appointments · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

10 public records
ME
Mikhail Eydelman

Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
PCVX executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 24, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

8 public records

Disclosure boundary

Governance and independence

Only current, confirmed leadership roles with public evidence are included in the canonical projection.

RecordStatusAuthorityEffective

Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.

Financials & Filings

Reported statements, original filings and proxy disclosures with their reporting periods.

Financial statements · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Filing library · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Proxy & Voting · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Ownership & Markets

Ownership, funding and dated financial information.

Ownership, control and market context · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Ownership disclosures retain their reporting dates and source types. Economic ownership, investment discretion and voting authority are distinct. Activism and settlement-dated short interest are not established by holdings or short-sale volume.

Risk & Assurance

Disclosed coverage, ratings and assurance scope.

Disclosures and oversight · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Credit-rating evidence, where published, appears in the Governance and Basis sections with its source and reporting date. Insurance coverage, cyber ratings and assurance reports require their own issuer, scope, date and usage rights. Indemnification does not establish insurance coverage.

Evidence & History

Identifiers, sources and record limitations.

Identifiers

Alpha ID
alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2
Record version
public-1

Sources

Sources and published information

Published evidence records

5 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 24, 2026

    Supports 4 claims
    • Legal Name: Vaxcyte, Inc. · Claim reviewed: Sep 24, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 24, 2026
    • Published Fact: US · Claim reviewed: Sep 24, 2026
    • Published Fact: Healthcare · Claim reviewed: Sep 24, 2026

  2. Vaxcyte Inc DEF 14A 2026-04-23

    sec proxy · Source published: Apr 23, 2026 · Retrieved: Apr 29, 2026

    Supports 8 claims
    • Leadership Role: Annie Drapeau: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Carlos Paya, M.D., Ph.D.: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Grant E. Pickering: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Halley Gilbert: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Jacks Lee: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: John Furey: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Olivier Brandicourt: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Teri Loxam: Director · Claim reviewed: Sep 24, 2026

  3. Vaxcyte Inc key executives

    other · Source published: Apr 22, 2026 · Retrieved: Apr 22, 2026

    Supports 7 claims
    • Leadership Role: Andrew L. Guggenhime: President & Chief Financial Officer · Claim reviewed: Sep 24, 2026
    • Leadership Role: Elvia Cowan: Senior Vice President of Finance · Claim reviewed: Sep 24, 2026
    • Leadership Role: Grant E. Pickering: Co-Founder, Chief Executive Officer & Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: James Wassil: Executive Vice President & Chief Operating Officer · Claim reviewed: Sep 24, 2026
    • Leadership Role: Janet Graesser: Senior Vice President of Corporate Affairs · Claim reviewed: Sep 24, 2026
    • Leadership Role: Sam Iki: Senior Vice President of Project Management · Claim reviewed: Sep 24, 2026
    • Leadership Role: Whitney Jones: Chief People Officer · Claim reviewed: Sep 24, 2026

  4. PCVX DEF 14A executive officers

    sec filing · Source published: Apr 23, 2026 · Retrieved: May 6, 2026

    Supports 2 claims
    • Leadership Role: Harp Dhaliwal: Chief Technical Operations Officer · Claim reviewed: Sep 24, 2026
    • Leadership Role: Jim Wassil: Executive Vice President and Chief Operating Officer · Claim reviewed: Sep 24, 2026

  5. PCVX executive roster source

    sec filing · Source published: May 3, 2026 · Retrieved: May 3, 2026

    Supports 1 claim
    • Leadership Role: Mikhail Eydelman: Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary · Claim reviewed: Sep 24, 2026